Skip to main content

Risk Warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 85.9% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please click here to read our full Risk Warning.

85.9% of retail investor accounts lose money when trading CFDs with this provider.

Zero commission fees for trading any crypto CFD

  • 0% commission fee
  • 0% swap for overnight positions
  • 0% commission for deposits
  • Tight spreads apply.

85.9% of retail investor accounts lose money

Available for retail clients on the Libertex Trading Platform

0% commission fee for any crypto CFD

Aphria Inc.

Aphria Inc. (ticker – APHA) is a Canadian company specializing in the production, supply and sale of medical cannabis for both the Canadian and international markets. It is headquartered in Leamington, Canada.

Since becoming licensed to produce and sell medical cannabis in 2014, the company's share price has risen more than ten-fold.

Revenue Aphria Inc.
According to its 2017 financial results, the company's income stood at CAD 20.4 million. It is projecting a 987% increase (to a total of CAD 201.3 million) for financial 2019.

Brand goodwill
Aphria is a major producer of medical cannabis. In 2018, the company completed a series of acquisitions within the sector as part of its strategy to expand into international markets.

Shares and quoted stock prices Aphria
The company's shares are traded on the American NYSE and Canadian TSX stock exchanges. With a unit share price of USD 8.83, the company's market capitalization stands at USD 2.05 billion.

Earnings potential
The company is demonstrating revenue growth of over 100% per annum and the industry has massive potential. Over the course of 2017, shares have risen by more than 500% and still have additional growth potential.